Kala Pharmaceuticals, a biopharmaceutical eye disease company, has tapped Francis Mah, MD, as its new chief medical adviser, according to a March 29 news release published in Street Insider.
Kala Pharmaceuticals, a biopharmaceutical eye disease company, has tapped Francis Mah, MD, as its new chief medical adviser, according to a March 29 news release published in Street Insider.